Oncology News

Patients with hepatocellular carcinoma who had neutrophil-lymphocyte ratios of 4 or greater after a liver transplant were more likely to experience recurrence in a recent study.

Patients with hepatocellular carcinoma were responsive to therapy with gemcitabine and oxaliplatin, with some able to undergo previously unfeasible curative treatments, in a recent study.

Ultrasonographic surveillance of gallbladder polyps, with or without subsequent surgery, would be cost-effective while aiding in the detection and prevention of gallbladder cancer, according to recent results.

HIV/HCV coinfected patients with advanced hepatic fibrosis were at increased risk for death, end-stage liver disease and carcinomas in a recent study.

Participants who reported intake of vitamin E via diet or nutritional supplements were at a decreased risk for liver cancer in a recent population-based study.

Patients with hepatocellular carcinomas had higher survival and disease control rates when treated with sorafenib compared with placebo, regardless of pretreatment disease characteristics, in a recent study.

Patients with unresectable hepatocellular carcinomas but otherwise normal livers may benefit from transplantation, according to recent results.

Patients with perihilar cholangiocarcinoma treated with neoadjuvant chemoradiation and liver transplantation experienced high rates of recurrence-free survival in a recent study.

Patients with hepatocellular carcinoma associated with hepatitis B may be more prone to early onset of cancer and poor prognosis than patients with carcinomas associated with hepatitis C, according to recent results that also indicated several other clinical-pathologic differences between the two.

Patients with hepatocellular carcinoma treated with sorafenib who experienced a reduction in alpha-fetoprotein levels had higher survival rates than those who did not in a recent retrospective analysis.